Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
- 1 March 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (4), 503-509
- https://doi.org/10.1016/s0959-8049(97)10090-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Current Status of Colorectal Cancer: CPT-11 (Irinotecan), a Therapeutic InnovationEuropean Journal Of Cancer, 1996
- Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF)European Journal Of Cancer, 1995
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancerThe Lancet, 1995
- Invited Review: Nutrition Support in Patients With Cancer: What Do the Data Really Show?Nutrition in Clinical Practice, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011JNCI Journal of the National Cancer Institute, 1988
- Total Parenteral Nutrition in the Cancer PatientNew England Journal of Medicine, 1981
- Reporting results of cancer treatmentCancer, 1981
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980